What Fios Genomics does

Fios Genomics is a UK-based bioinformatics services firm that delivers biological interpretation of complex omics data to pharmaceutical, biotechnology, and academic research organisations. The company's core offering is a portfolio of specialised analytical modules covering gene expression, single-cell, genetic variation, proteomics, metabolomics, epigenetics, and clinical data analysis, applied across multiple species and therapeutic areas including oncology, cardiovascular and metabolic disease, CNS, rare diseases, and cell and gene therapy. The firm complements its client-data analysis services with FG DataMine, a proprietary service that enables mining of public biological databases when primary client data is unavailable.

The underlying technology stack is built on established bioinformatics workflows (e.g., limma-voom for RNA sequencing) rather than proprietary AI/ML models, with differentiation stemming from methodological breadth, species-agnostic flexibility, and the ability to handle both large and small data volumes. Recent product additions include Target Triage, a service designed to prioritise candidate drug targets for validation, and a Cell and Gene Therapy Bioinformatics offering, both indicating an expansion of the analytical product surface.

Fios Genomics operates on a professional services revenue model with quote-based, project-driven pricing and multi-year contract cadence. Customer acquisition is predominantly direct and inbound through website enquiry forms, supplemented by approved-vendor presence on Science Exchange and Scientist.com procurement marketplaces. The company markets itself through content-driven thought leadership, including blogs, white papers, case studies, and publication acknowledgements. It reports 1500+ completed projects, 300+ clients globally, and 100+ publication acknowledgements. The company is privately held with no disclosed funding rounds, acquisitions, or institutional investor backing.

Name

Fios Genomics

Legal name

Fios Genomics Ltd

Website

https://fiosgenomics.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Fios Genomics is a UK-based bioinformatics services provider offering biological interpretation of multi-omics data across gene expression, single-cell, proteomics, metabolomics, and clinical domains to pharmaceutical, biotechnology, and academic research organisations on a project basis.

Ownership category

akta.pro rank

Product category

Bioinformatics Analysis Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)

akta.pro secondary industries

Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics) (HLAAANAF), Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation) (HLAAAIAI), Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

Keywords

• Bioinformatics analysis services
• Omics data interpretation
• Drug discovery bioinformatics
• Clinical biomarker analysis
• Pharmaceutical data analysis

Headquarters

HQ city

Edinburgh

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Bioinformatics Analysis Services: Fios Genomics generates revenue through providing bioinformatics analysis services on a project basis. Services include gene expression analysis, single-cell analysis, genetic variation analysis, proteomics, metabolomics, epigenetics, clinical data analysis, and more. Clients submit data for analysis and receive detailed biological interpretation reports. Pricing is quote-based, reflecting the custom nature of each engagement.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

Fios Genomics provides bioinformatics analysis services that interpret complex omics data to accelerate drug discovery, development, and academic research. Its offerings span gene expression, single-cell, genetic variation, proteomics, metabolomics, epigenetics, and clinical data analysis, complemented by Target Triage for drug target prioritisation, FG DataMine for public database mining, and a specialised Cell and Gene Therapy Bioinformatics service. Engagements are species-agnostic and support both large and small data volumes across multiple therapeutic areas.

Product overview

Fios Genomics provides a portfolio of bioinformatics analysis services to pharmaceutical, biotechnology, and academic organizations for drug discovery, development, and applied research. Their offering is a consultative service model organized around multiple specialized analysis modules: the core Bioinformatics Services encompass gene expression, single-cell, genetic variation, proteomics, metabolomics, epigenetics, and clinical data analysis. These core services are complemented by specialized offerings including Target Triage (new drug target selection service), FG DataMine (public database mining tool), and Cell and Gene Therapy Bioinformatics. Services are also organized by therapeutic applications including Oncology, Cardiovascular & Metabolic Disease, Gastrointestinal, Infections & Vaccines, Respiratory, Dermatology, CNS, Rare Diseases, and Environmental & Agricultural. The company reports having completed over 1,500 projects and published over 100 publication acknowledgements.

Differentiator

Problem solved

Functional benefit

Products and services

• Bioinformatics Analysis Services End-to-end bioinformatics analysis services that deliver biological interpretation of omics data for pharmaceutical, biotechnology, and academic research organisations. Engagements cover pre-clinical and clinical development, biomarker discovery, and drug repositioning, and accept both large and small data volumes across multiple species.
• Target Triage A drug discovery support service that identifies the most suitable candidate drug targets to take forward to validation, enabling faster and smarter target selection for pharmaceutical and biotechnology research programmes.
• FG DataMine A proprietary data mining and landscaping capability that enables clients to access and analyse publicly available biological databases when their own primary data is unavailable or insufficient.
• Cell and Gene Therapy Bioinformatics Specialised bioinformatics analysis service tailored to cell and gene therapy research and development programmes for pharmaceutical, biotechnology, and academic research organisations.
• ScaleBio QuantumScale Data Analysis Boutique single-cell data analysis service offered in partnership with ScaleBio to analyse QuantumScale single-cell sequencing data for research clients.

Quantifiable outcome

• 1500+ closed projects completed
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Three partnerships are on record, tiered minor and core.

• Science ExchangeminorChannel Partner/ Reseller/ DistributorFios Genomics is listed as an approved vendor on Science Exchange, a platform that connects researchers with approved service providers. This partnership provides access to Science Exchange's researcher customer base and validates the company's quality standards for external verification.
• Scientist.comminorChannel Partner/ Reseller/ DistributorFios Genomics is listed as an approved vendor on Scientist.com's marketplace, which enables researchers to procure bioinformatics services through the platform's compliant procurement system used by pharmaceutical and biotech companies.
• ScaleBiocoreTechnology or IntegrationFios Genomics has partnered with ScaleBio to offer data analysis services for ScaleBio's QuantumScale single-cell sequencing technology. This is highlighted as a featured service offering on the Fios Genomics website, indicating a strategic integration partnership for single-cell analysis services.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Velsera (Seven Bridges Genomics): Provides bioinformatics analysis services and cloud platforms for multi-omics data interpretation to pharma, biotech, and academic customers. Directly competes with Fios in delivering project-based bioinformatics analysis across genomic and multi-omic data types.
• Genedata: Offers enterprise bioinformatics software and analysis services for pharmaceutical R&D across omics data types, including biomarker discovery and target identification. Closely aligned with Fios's multi-omics analysis focus for pharma and biotech customers.
• DNAnexus: Cloud-based bioinformatics platform providing data analysis and management for genomics and multi-omics research, used by pharma, biotech, and academic organizations. Overlaps with Fios in serving enterprise omics interpretation needs.
• Partek (Illumina): Provides bioinformatics software for gene expression, single-cell, and multi-omics analysis. Targets similar pharma and academic customers seeking accessible omics analysis tools and services as Fios does.

Emerging players

• Qlucore: Specialized bioinformatics software company offering omics visualization and analysis for life sciences research. Overlaps with Fios in providing analysis for gene expression and multi-omics data to research customers.

Broad incumbents

• QIAGEN Digital Insights: QIAGEN's bioinformatics arm delivers genomics and clinical interpretation platforms and services to pharma, biotech, and clinical customers. As a broad incumbent, it overlaps with Fios's offerings but at much larger scale and with software-led delivery.
• Eurofins Genomics: Global genomics services provider offering sequencing and bioinformatics analysis to pharma, biotech, and academic customers. Competes in multi-omics analysis services globally with a broader wet-lab plus bioinformatics model.
• Novogene: Global multi-omics services company providing sequencing and bioinformatics analysis to research customers. Overlaps directly with Fios's full-service bioinformatics interpretation offerings across genomics, transcriptomics, and proteomics.
• BGI Genomics: Large-scale genomics and multi-omics services provider to academic and pharma customers globally, with integrated sequencing and bioinformatics offerings. Represents a global incumbent alternative for omics analysis services.

Others

• Clarivate (Life Sciences & Healthcare): Provides data, analytics, and software-driven research intelligence for pharma and biotech. Adjacent to Fios through serving the same customer base with life-sciences research decision support rather than direct bioinformatics analysis services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/fiosgenomics
• YouTubeyoutube.com/@fiosgenomics
• Facebookfacebook.com/fiosgenomics
• LinkedInlinkedin.com/company/fios-genomics-ltd

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fios Genomics